Vishnu Chemicals Q1: consolidated PAT ₹39.6 Cr up 23% YoY, revenue climbs 25% on overseas

Vishnu Chemicals opened FY27 with consolidated revenue of ₹433.4 Cr, up 24.9% YoY from ₹346.9 Cr, and net profit of ₹39.6 Cr, up 23.0% from ₹32.2 Cr a year ago (EPS ₹5.89 vs ₹4.79). The growth was almost entirely export-led: overseas sales rose ~52% YoY to ₹239.4 Cr while domestic revenue was broadly flat at ₹192.7 Cr, consistent with management's prior-call thesis of favourable chrome and barium demand in the US and Europe and the Strontium Carbonate ramp flagged for this quarter. On that count the print confirms the confident, growth-oriented guidance given on the Q3 FY26 concall rather than contradicting it.

Profitability, however, grew slightly slower than the topline. PBT actually rose 31.7% YoY to ₹55.1 Cr, but the consolidated tax rate climbed to 28% (from 23% a year ago) and pulled PAT growth down to 23%. Operating margin compressed to roughly 15% from ~16% a year earlier as finance costs jumped to ₹12.1 Cr (from ₹8.4 Cr YoY and just ₹4.9 Cr in Q4) and manufacturing expenses rose; net margin held flat at ~9.1% only because other income more than doubled to ₹12.9 Cr. Sequentially the quarter was softer — revenue -3.8% and PAT -8.7% versus a seasonally strong Q4 FY26 (₹450.3 Cr / ₹43.4 Cr) — but YoY is the cleaner read and it is firmly positive.

The stock went into the print at ₹610, down 3.3% over the past month of trading.

For context: this is the second-highest quarterly PAT of the last 6 quarters; PAT has now risen for 3 consecutive quarters.

Standalone PAT ₹31.9 Cr (+77% YoY) on revenue ₹297.7 Cr (+13% YoY) — board set Aug 21 dividend record date, Aug 28 AGM

No brokerage consensus is published for this small-cap, so the print can't be graded against a street number, and there is no formal quantitative revenue/profit guidance on record beyond the FY28 target of a 20% consolidated EBITDA margin — against which this quarter's ~15% shows the gap management intends to close via its ~₹300 Cr FY27 capex (DMSO, capacity, backward integration). Alongside results the board set an August 21 dividend record date and an August 28 AGM. The main watch is whether the sharply higher finance cost is a one-quarter step-up tied to the capex cycle or a structural drag on margins as the spend builds.